AKT1 and cardiac hypertrophy: Therefore, IDO1 may activate AKT-mTOR signaling via KYN-PI3K signaling pathway.Interestingly, this is also the first study that showed the notion that AKT inhibitor perifosine can serve as a potential drug for cardiac hypertrophy treatment.